Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × talazoparib × Clear all

NCT04821622 2026-03-11

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Phase 3 Active not recruiting

Prostatic Neoplasms